Roots Analysis

Owing to various reasons, such as growing manufacturing demand, need for specialized facilities, equipment and operational expertise, and high costs of development associated with certain drugs / therapies, a number of ophthalmic drug developers have demonstrated a preference to outsource certain aspects of drug development and production operations to contract service providers. The USD 1.7 billion financial opportunity (by 2030) within the Ophthalmic Drugs Contract Manufacturing Market has been analyzed across the following segments: Type of product • Ophthalmic API • Ophthalmic drug FDF Type of FDF manufactured • Solid • Semi-solid • Liquid / suspension Type of primary packaging • Ampoule / vial • Glass / plastic bottle • Ointment tube • Blister packing • Other forms Scale of manufacturing • Clinical • Commercial Company size • Small • Mid-sized • Large • Very large Target disease indication • Age-related macular degeneration • Dry eye • Glaucoma • Other disease segments Key geographical regions • North America (US, Canada and Mexico) • Europe (UK, Germany, France, Spain, Italy and rest of Europe) • Asia-Pacific (India, China, Japan, Australia and rest of Asia-Pacific) • Rest of the world The Ophthalmic Drugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms (Ophthalmic Drops, Emulsions, Gels, Injections, Lotions, Ointments, Suspensions, and Tablets / Capsules), 2020-2030 report features the following companies, which we identified to be key players in this domain: • Akorn • Akums • Bal Pharma • Catalent • Cayman Chemical • Entod Pharmaceuticals • Farmigea • Glenmark Pharmaceuticals • Indiana Ophthalmics • Lomapharm • Medichem • Pillar5 Pharma • Recipharm • Salvat • Sterling Pharmaceutical Services • Sunways India Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Current Market Landscape 5. Company Competitiveness Analysis 6. Ophthalmic Drugs Contract Manufacturing in North America: Company Profiles 7. Ophthalmic Drugs Contract Manufacturing in Europe: Company Profiles 8. Ophthalmic Drugs Contract Manufacturing in Asia-Pacific: Company Profiles 9. Clinical Trial Analysis 10. Capacity Analysis 11. Demand Analysis 12. Market Forecast 13. Case Study: Comparison of Small Molecule and Large Molecule Ophthalmic Drugs / Therapies 14. SWOT Analysis 15. Survey Analysis 16. Executive Insights 17. Future Growth Opportunities 18. Appendix 1: List of Ophthalmic Medical Device Contract Manufacturers 19. Appendix 2: Tabulated Data 20. Appendix 3: List of Companies and Organizations For more information, please click on the following link: https://www.rootsanalysis.com/reports/view_document/ophthalmic-drugs-cmo/294.html About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact Information Roots Analysis Private Limited Gaurav Chaudhary +1 (415) 800 3415 Gaurav.Chaudhary@rootsanalysis.com